Optiver Holding
ANRO icon

Optiver Holding’s Alto Neuroscience ANRO Stock Holding History

Optiver Holding’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
112
+108
+2,700% +$2.5K ﹤0.01% 2177
2026
Q1 		$90 Sell
4
-16
-80% -$297 ﹤0.01% 2245
2025
Q4 		$356 Hold
20
– – ﹤0.01% 2325
2025
Q3 		$80 Buy
+20
New +$66 ﹤0.01% 2604

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Optiver Holding's ANRO Position: Q2 2026 in Review

Optiver Holding increased its Alto Neuroscience (ANRO) stake by 2,700% in Q2 2026, buying an estimated $2.5K and bringing the position to 112 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

Optiver Holding first reported a position in ANRO in Q3 2025 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Optiver Holding held 112 shares of Alto Neuroscience worth $2.96K as of Q2 2026.
  • Optiver Holding bought 108 Alto Neuroscience shares in Q2 2026, an estimated $2.5K.
  • Alto Neuroscience made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2177 holding.
  • Optiver Holding first reported a position in Alto Neuroscience in Q3 2025 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.